Inovio Pharmaceuticals: Funding, Investors & Team (Oct 2026)
INOVIO is a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat, cure, and protect people from diseases associated with HPV, cancer, and infectious diseases. INOVIO is the first and only company to have clinically demonstrated that DNA medicine can be delivered directly into cells in the body via a proprietary smart device to produce a robust and tolerable immune response. Specifically, INOVIO's lead candidate VGX-3100, currently in Phase 3 trials for precancerous cervical dysplasia, demonstrated it destroyed and cleared high-risk HPV 16 and 18 in a Phase 2b clinical trial. High-risk HPV is responsible for 70% of cervical cancer, 90% of anal cancer, and 69% of vulvar cancer.
Inovio Pharmaceuticals has raised $17.5M across 1 funding round on record, the most recent an undisclosed round of $17.5M announced in Apr 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Inovio Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Inovio Pharmaceuticals Funding Rounds
Inovio Pharmaceuticals Founders and Leadership Team
Contact details for the Inovio Pharmaceuticals team: 1 of 1 has an email address on file.
Start 14-day free trial →Inovio Pharmaceuticals Funding Compared to Other Biotechnology Startups
Inovio Pharmaceuticals' latest round of $17.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Inovio Pharmaceuticals in Biotechnology and Plymouth Meeting
Companies Similar to Inovio Pharmaceuticals
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Inovio Pharmaceuticals Funding FAQs
What does Inovio Pharmaceuticals do?
INOVIO is a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat, cure, and protect people from diseases associated with HPV, cancer, and infectious diseases. INOVIO is the first and only company to have clinically demonstrated that DNA medicine can be delivered directly into cells in the body via a proprietary smart device to produce a robust and tolerable immune response. Specifically, INOVIO's lead candidate VGX-3100, currently in Phase 3 trials for precancerous cervical dysplasia, demonstrated it destroyed and cleared high-risk HPV 16 and 18 in a Phase 2b clinical trial. High-risk HPV is responsible for 70% of cervical cancer, 90% of anal cancer, and 69% of vulvar cancer.
How much funding has Inovio Pharmaceuticals raised?
Inovio Pharmaceuticals has raised $17.5M across 1 round on record. The most recent is an undisclosed round of $17.5M announced in Apr 2026.
When did Inovio Pharmaceuticals last raise funding?
Inovio Pharmaceuticals' most recent funding round on record is an undisclosed round of $17.5M, announced in Apr 2026.
Who founded Inovio Pharmaceuticals?
FundedIQ lists Jacqueline Shea (Founder) at Inovio Pharmaceuticals.
Where is Inovio Pharmaceuticals headquartered?
Inovio Pharmaceuticals is based in Plymouth Meeting, Pennsylvania, United States.
How many employees does Inovio Pharmaceuticals have?
Inovio Pharmaceuticals is in the 101-250 employee band.
How does Inovio Pharmaceuticals' funding compare to other Biotechnology startups?
Inovio Pharmaceuticals' latest round of $17.5M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Inovio Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Inovio Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.